Statements (53)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:medicine
|
| gptkbp:abbreviation |
gptkb:MedDRA
|
| gptkbp:contains |
adverse event terms
device terms indication terms investigation terms medical history terms medical terms medication error terms product administration errors product issue terms product manufacturing issues product quality terms product supply issues product use issues social circumstances terms surgical and medical procedures |
| gptkbp:developedBy |
gptkb:International_Council_for_Harmonisation_of_Technical_Requirements_for_Pharmaceuticals_for_Human_Use
|
| gptkbp:firstReleased |
1999
|
| gptkbp:fullName |
Medical Dictionary for Regulatory Activities
|
| gptkbp:governedBy |
MedDRA Management Committee
|
| gptkbp:hasHierarchy |
High Level Group Term
High Level Term Lowest Level Term Preferred Term System Organ Class |
| https://www.w3.org/2000/01/rdf-schema#label |
MedDRA
|
| gptkbp:language |
gptkb:Chinese
gptkb:French gptkb:German gptkb:Russian gptkb:Spanish English Japanese Portuguese |
| gptkbp:license |
yes
|
| gptkbp:relatedTo |
gptkb:SNOMED_CT
gptkb:ICD-10 WHO Adverse Reaction Terminology |
| gptkbp:updated |
twice a year
|
| gptkbp:usedBy |
gptkb:contract_research_organizations
healthcare professionals pharmaceutical companies regulatory authorities |
| gptkbp:usedFor |
pharmacovigilance
adverse event classification regulatory communication |
| gptkbp:usedIn |
clinical trials
post-marketing surveillance |
| gptkbp:website |
https://www.meddra.org/
|
| gptkbp:bfsParent |
gptkb:Ontology_for_Vaccine_Adverse_Events
gptkb:MSSO |
| gptkbp:bfsLayer |
7
|